Apollomics Inc.

Contributing Author

Recent Articles by Apollomics Inc.

Jul-13	Apollomics Regains Full Compliance with Nasdaq Listing Requirements APLM -25.01% GlobeNewswire
Jun-24	Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia APLM APLM +7.32% GlobeNewswire
Apr-27	Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress APLM GlobeNewswire
Apr-01	Apollomics Inc. Announces $2.0 Million Bridge Financing APLM -7.13% GlobeNewswire
Dec-22	Apollomics Reports First Half 2025 Financial Results APLM +10.55% APLM -6.81% GlobeNewswire
Nov-19	Apollomics Announces Settlement of Cayman Litigation APLM APLM -17.51% GlobeNewswire
Nov-17	Apollomics Announces Changes to its Board of Directors and Composition of Committees APLM -14.50% GlobeNewswire
Oct-15	Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation APLM +5.79% APLM +64.00% GlobeNewswire
Oct-15	Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation APLM +5.79% APLM +64.00% GlobeNewswire